News for 'FDA'

US regulators recommend pause on J&J vaccine over rare blood clots

US regulators recommend pause on J&J vaccine over rare blood clots

Rediff.com13 Apr 2021

In a joint statement, the CDC and the FDA said they were investigating clots in six women in the days after vaccination, in combination with reduced platelet count.

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Rediff.com17 Sep 2021

Pfizer can show the FDA approval to the Indian regulator and present a case that based on whatever data submitted, the US regulator has granted a full marketing nod, says Sohini Das.

Mutual funds turn upbeat on health care sector, divided on IT prospects

Mutual funds turn upbeat on health care sector, divided on IT prospects

Rediff.com25 Jul 2023

Mutual funds (MFs) are betting on a turnaround in the healthcare sector to boost returns but are divided on the prospects of the information technology (IT) sector amid uncertain growth outlook. At the end of June, all of the top 20 fund houses were overweight on the healthcare sector vis--vis the sector's presence in the BSE 200 index, shows a report by Motilal Oswal Financial Services (MOFS). In the case of the IT sector, only six of the 20 fund houses had overweight positions.

Indian drug firm recalls eye drop linked to vision loss in US

Indian drug firm recalls eye drop linked to vision loss in US

Rediff.com3 Feb 2023

Global Pharma Healthcare is recalling entire lots of eye drop linked to vision loss in the US, according to the US Food and Drug Administration. The Chennai-based company is recalling all lots of artificial tears lubricant eye drops distributed by EzriCare, LLC and Delsam Pharma to the consumer level due to possible contamination, the US health regulator said in a statement. "The Centres for Disease Control and Prevention (CDC) alerted FDA to an investigation of a multi-state cluster of Verona Integron-mediated Metallo--lactamase (VIM)- and Guiana-Extended Spectrum--Lactamase (GES)- producing carbapenem-resistant Pseudomonas aeruginosa (VIM-GES-CRPA) infections possibly associated with the use of the artificial tears manufactured by Global Pharma Healthcare," USFDA said.

US authorises Moderna vaccine for emergency use

US authorises Moderna vaccine for emergency use

Rediff.com19 Dec 2020

According to an official statement, the FDA has determined that the Moderna COVID-19 vaccine has met the statutory criteria for issuance of an emergency use authorisation (EUA).

Day after US debate, buzz over Vivek Ramaswamy grows as does fundraising

Day after US debate, buzz over Vivek Ramaswamy grows as does fundraising

Rediff.com25 Aug 2023

Indian-American multimillionaire biotech entrepreneur Vivek Ramaswamy's popularity rating and online fundraising have surged, a day after his impressive performance at the first Republican presidential primary debate.

Alonso apologises to 'legend' Hamilton after Spa spat

Alonso apologises to 'legend' Hamilton after Spa spat

Rediff.com1 Sep 2022

Alonso said he had huge respect for Hamilton and had no problems with him.

US allows use of plasma treatment for COVID patients

US allows use of plasma treatment for COVID patients

Rediff.com24 Aug 2020

The US Food and Drug Administration said on Sunday that over 70,000 patients in the country had been treated with convalescent plasma, which is made using the blood of people who have recovered from coronavirus infections.

Maharashtra FDA raps Subhiksha

Maharashtra FDA raps Subhiksha

Rediff.com14 Aug 2008

The regulator has also cancelled the licences of three packagers providing services to Subhiksha for violating the packaging rules. The warehouses are based in Bhiwandi, which is on the outskirts of Mumbai.

US withdraws emergency use of hydroxychloroquine for Covid-19

US withdraws emergency use of hydroxychloroquine for Covid-19

Rediff.com15 Jun 2020

The Food and Drug Administration said its decision is based on new information, including clinical trial data results, that have led it to conclude that the drugs may not be effective to treat COVID-19 and that its potential benefits for such use do not outweigh its known and potential risks.

USFDA pulls up Sun Pharma for lapses in Halol plant

USFDA pulls up Sun Pharma for lapses in Halol plant

Rediff.com14 Jan 2023

The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate written procedures designed to prevent microbiological contamination of drug products, at its Gujarat-based plant. In a warning letter, the US Food and Drug Administration (USFDA) pointed out various lapses at the Halol plant which produces finished pharmaceutical products. "This warning letter summarises significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals... Because your methods, facilities, or controls for manufacturing, processing, packing, or holding do not conform to CGMP, your drug products are adulterated," the USFDA stated.

Ajit Pawar and men win big, Shinde and Co lose out in Maharashtra portfolios

Ajit Pawar and men win big, Shinde and Co lose out in Maharashtra portfolios

Rediff.com14 Jul 2023

Nationalist Congress Party leader Ajit Pawar was given the finance and planning portfolio on Friday, nearly two weeks after he broke away from the original party and took oath as Maharashtra's deputy chief minister.

Why Zydus is likely to continue with its outperformance

Why Zydus is likely to continue with its outperformance

Rediff.com31 Mar 2023

Even as most of its large-cap pharmaceutical peers have struggled to stay above water on the returns front, Zydus Lifesciences has been one of the big outperformers within the sector over the past year with a return of over 30 per cent. The gains have come on the back of multiple triggers such as the scaling up of new product launches in the US market, clearance for its Moraiya (Gujarat) facility and steady performance in the domestic market. Though it has been the top pharma gainer in the 2022-23 financial year (FY23), brokerages continue to maintain their 'buy' stance, given the strong visibility in the US market.

US can declare 'independence' from China with India's help: Vivek Ramaswamy

US can declare 'independence' from China with India's help: Vivek Ramaswamy

Rediff.com27 Aug 2023

He is currently on a two-day swing to the crucial State of Iowa. On January 15, Iowa would kick off the 2024 Republican presidential primary season.

Pfizer Covid vaccine gets US experts' nod

Pfizer Covid vaccine gets US experts' nod

Rediff.com11 Dec 2020

The Pfizer vaccine has already been approved for the public in the United Kingdom and, Canada.

Pfizer withheld Covid vaccine news before elections: Trump

Pfizer withheld Covid vaccine news before elections: Trump

Rediff.com10 Nov 2020

Trump had said that he worked on removing a large number of bureaucratic obstacles to fast-track development and approval of a vaccine.

Eye disease drug may stop reproduction of coronavirus, says study

Eye disease drug may stop reproduction of coronavirus, says study

Rediff.com9 Nov 2022

Signalling pathways are complicated chain reactions which control many important human biological processes and in which certain proteins act as messenger molecules that promote or block the signals of other proteins.

Pharma funds: 'Enter with a horizon of 5-7 years or more'

Pharma funds: 'Enter with a horizon of 5-7 years or more'

Rediff.com14 Mar 2023

In contrast with their strong performance in 2020 and 2021, pharmaceutical and healthcare funds experienced a decline in 2022, with returns plummeting by an average 9.8 per cent. This trend has continued in the current year, with year-to-date return remaining in the negative (-4.9 per cent). In the past three months, pharma funds have been hit hard, experiencing a 7.9 per cent decline.

Hand over central lab report to J&J: HC tells Maha

Hand over central lab report to J&J: HC tells Maha

Rediff.com27 Oct 2022

A vacation bench of Justices NJ Jamadar and Sharmila Deshmukh passed the decision on Wednesday while hearing a petition filed by the company challenging two orders of the state government.

Cadila gets tentative FDA nod

Cadila gets tentative FDA nod

Rediff.com15 Jun 2006

Cadila Healthcare Ltd has received tentative approval from the USFDA to market Pravastatin Sodium Tablets in the US market.

'ChatGPT' Vivek Ramaswamy in 2nd spot behind Trump after US debate

'ChatGPT' Vivek Ramaswamy in 2nd spot behind Trump after US debate

Rediff.com24 Aug 2023

Former New Jersey Governor Chris Christie and a Republican presidential aspirant have called his fellow rival Indian-American Vivek Ramaswamy a guy who sounds like ChatGPT and described him as an "amateur" Barack Obama.

Madhuri Dixit gets FDA notice for endorsing Maggi

Madhuri Dixit gets FDA notice for endorsing Maggi

Rediff.com29 May 2015

If the actress fails to respond to the notice within the stipulated time frame, a case could be registered against her, Food Security Officer Mahimanand Joshi said.

Ferrari wants women drivers for its motor racing academy

Ferrari wants women drivers for its motor racing academy

Rediff.com13 Dec 2019

Ferrari are planning to add female racers to their expanding young driver programme as they seek to develop talent for the future.

US sets new record with over 3,000 COVID deaths in 1 day

US sets new record with over 3,000 COVID deaths in 1 day

Rediff.com10 Dec 2020

The previous single-day record was on May 7 at 2,769 deaths.

'Red Bull' under FDA lens

'Red Bull' under FDA lens

Rediff.com13 Jul 2005

Maharashtra Food and Drug Administration has prohibited the sales of 'Red Bull', an energy drink, following complaints that the product's main ingredient Taurine is an animal derivative, which the company denies saying it is derived sythetically.

Travel restrictions imposed after 1st coronavirus death in US

Travel restrictions imposed after 1st coronavirus death in US

Rediff.com1 Mar 2020

Vice President Mike Pence said Trump had authorised a ban on entry of foreign nationals who travelled to Iran in the last 14 days. The United States also advised its citizens not to travel to parts of South Korea and Italy, from where reports of coronavirus have appeared.

FDA diktat on 'wonder' drugs

FDA diktat on 'wonder' drugs

Rediff.com20 Apr 2005

Alarmed by the growing number of advertisements on 'miracle' drugs being shown on television channels, Maharashtra Food and Drug Administration

Ranbaxy drug gets FDA nod

Ranbaxy drug gets FDA nod

Rediff.com1 Feb 2005

Ranbaxy Laboratories has received approval from the U.S. Food and Drug Administration to manufacture and market Clarithromycin XL 1,000 mg tablets.

FDA cracks down on Bisleri

FDA cracks down on Bisleri

Rediff.com25 Oct 2004

The Maharashtra Food and Drug Administration on Monday ordered Parle Bisleri, manufacturer of Bisleri mineral water to stop production in its two units in Mumbai with immediate effect.

Trials find Covid vax safe for kids aged 5-11 yrs: Pfizer, BioNTech

Trials find Covid vax safe for kids aged 5-11 yrs: Pfizer, BioNTech

Rediff.com20 Sep 2021

Pfizer and BioNTech SE on Monday said trial results of COVID-19 vaccine showed that it is safe and produced robust neutralising antibody response in children aged five to 11 years, and they plan to seek regulatory approvals as soon as possible.

Schumi Jr's dream comes true as he takes first step on F1 journey

Schumi Jr's dream comes true as he takes first step on F1 journey

Rediff.com2 Dec 2020

Mick Schumacher, who will face intense scrutiny as embarks on his Formula One career, said for now he was simply overwhelmed to be following in his father's footsteps and called his promotion a dream come true.

US approves Johnson & Johnson's Covid vaccine

US approves Johnson & Johnson's Covid vaccine

Rediff.com28 Feb 2021

The Johnson and Johnson vaccine, which works with one dose instead of two, got approval on Saturday, the third vaccine cleared in the country after emergency use authorisation (EUA) was given to two-dose shots from Pfizer and Moderna in December last year.

US eases travel advisory for India

US eases travel advisory for India

Rediff.com17 Aug 2021

The new travel advisory came in the wake of the significant improvement in Covid situation in India.

US lifts Covid curbs on fully-vaccinated travellers from Nov 8

US lifts Covid curbs on fully-vaccinated travellers from Nov 8

Rediff.com26 Oct 2021

The US will lift all restrictions for fully vaccinated international travellers, including from India, from November 8 but they will have to show proof of a negative coronavirus test before boarding a flight to the country, the White House has announced.

Pfizer moves US court against Aurobindo, Dr Reddy's over cancer drug

Pfizer moves US court against Aurobindo, Dr Reddy's over cancer drug

Rediff.com17 Nov 2020

Pfizer Inc and its group companies filed a petition in a US court against Aurobindo Pharma Ltd and Dr Reddy's Laboratories alleging that the Indian drug-makers were planning separately to come out with generic versions of its blockbuster multi-billion dollar drug Ibrance (palbociclib) before expiration of its patent.

Sterilisation botch-up: FDA seals drug unit in Raipur

Sterilisation botch-up: FDA seals drug unit in Raipur

Rediff.com13 Nov 2014

The drug controlling authority in Chhattisgarh on Thursday raided and sealed a unit of an antibiotic manufacturing company, whose product was used in sterilisation camps in Bilaspur district where 13 women died and several others fell ill.

A bitter pill for Aurobindo's sterile drug unit

A bitter pill for Aurobindo's sterile drug unit

Rediff.com25 Nov 2019

USFDA issues Form 483 with as many as 14 observations that could impact ongoing operations at Aurobindo's Pashamailaram facility in Hyderabad.

Ranbaxy gets FDA nod for Topiramate

Ranbaxy gets FDA nod for Topiramate

Rediff.com17 Dec 2004

Pharma major Ranbaxy Laboratories Ltd on Friday said it has received tentative approval from the US Food and Drug Administration to manufacture and market 25 mg, 100 mg and 200 mg Topiramate tablets.

How Dr Reddy's plans to win the US market

How Dr Reddy's plans to win the US market

Rediff.com17 Mar 2017

The company has launched only 3 new products during 2015 when compared to 14 launches in 2014

Ranbaxy gets FDA nod for drugs

Ranbaxy gets FDA nod for drugs

Rediff.com9 Sep 2004

Ranbaxy Laboratories has received tentative approval from the US Food and Drug Administration to manufacture and market Fosinopril Sodium and Hydrochlorothiazide tablets in 10 mg/12.5 mg and 20 mg/12.5 mg strengths